Acurx Pharmaceuticals, Inc. to Discuss 2022 Third Quarter Financial Results on November 14, 2022 Conference Call and Provide Business Update
- Tuesday, November 1, 2022, 7:03
- Finance
- Add a comment
STATEN ISLAND, N.Y., Nov. 1, 2022 /PRNewswire/ — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that the Company will…
About the Author
adminasapcorp has written 38426 stories on this site.